Global Biosimilar Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Biosimilar Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Biosimilar by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Biosimilar by Country/Region, 2017, 2022 & 2028

2.2 Biosimilar Segment by Type

2.2.1 Human Growth Hormones

2.2.2 Monoclonal Antibodies

2.2.3 Insulin

2.2.4 Peptides

2.2.5 Erythropoietin

2.2.6 Others

2.3 Biosimilar Sales by Type

2.3.1 Global Biosimilar Sales Market Share by Type (2017-2022)

2.3.2 Global Biosimilar Revenue and Market Share by Type (2017-2022)

2.3.3 Global Biosimilar Sale Price by Type (2017-2022)

2.4 Biosimilar Segment by Application

2.4.1 Oncology

2.4.2 Chronic and Autoimmune Diseases

2.4.3 Growth Hormone Deficiency

2.4.4 Infectious Diseases

2.4.5 Others

2.5 Biosimilar Sales by Application

2.5.1 Global Biosimilar Sale Market Share by Application (2017-2022)

2.5.2 Global Biosimilar Revenue and Market Share by Application (2017-2022)

2.5.3 Global Biosimilar Sale Price by Application (2017-2022)

3 Global Biosimilar by Company

3.1 Global Biosimilar Breakdown Data by Company

3.1.1 Global Biosimilar Annual Sales by Company (2020-2022)

3.1.2 Global Biosimilar Sales Market Share by Company (2020-2022)

3.2 Global Biosimilar Annual Revenue by Company (2020-2022)

3.2.1 Global Biosimilar Revenue by Company (2020-2022)

3.2.2 Global Biosimilar Revenue Market Share by Company (2020-2022)

3.3 Global Biosimilar Sale Price by Company

3.4 Key Manufacturers Biosimilar Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Biosimilar Product Location Distribution

3.4.2 Players Biosimilar Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Biosimilar by Geographic Region

4.1 World Historic Biosimilar Market Size by Geographic Region (2017-2022)

4.1.1 Global Biosimilar Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Biosimilar Annual Revenue by Geographic Region

4.2 World Historic Biosimilar Market Size by Country/Region (2017-2022)

4.2.1 Global Biosimilar Annual Sales by Country/Region (2017-2022)

4.2.2 Global Biosimilar Annual Revenue by Country/Region

4.3 Americas Biosimilar Sales Growth

4.4 APAC Biosimilar Sales Growth

4.5 Europe Biosimilar Sales Growth

4.6 Middle East & Africa Biosimilar Sales Growth

5 Americas

5.1 Americas Biosimilar Sales by Country

5.1.1 Americas Biosimilar Sales by Country (2017-2022)

5.1.2 Americas Biosimilar Revenue by Country (2017-2022)

5.2 Americas Biosimilar Sales by Type

5.3 Americas Biosimilar Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Biosimilar Sales by Region

6.1.1 APAC Biosimilar Sales by Region (2017-2022)

6.1.2 APAC Biosimilar Revenue by Region (2017-2022)

6.2 APAC Biosimilar Sales by Type

6.3 APAC Biosimilar Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Biosimilar by Country

7.1.1 Europe Biosimilar Sales by Country (2017-2022)

7.1.2 Europe Biosimilar Revenue by Country (2017-2022)

7.2 Europe Biosimilar Sales by Type

7.3 Europe Biosimilar Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Biosimilar by Country

8.1.1 Middle East & Africa Biosimilar Sales by Country (2017-2022)

8.1.2 Middle East & Africa Biosimilar Revenue by Country (2017-2022)

8.2 Middle East & Africa Biosimilar Sales by Type

8.3 Middle East & Africa Biosimilar Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Biosimilar

10.3 Manufacturing Process Analysis of Biosimilar

10.4 Industry Chain Structure of Biosimilar

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Biosimilar Distributors

11.3 Biosimilar Customer

12 World Forecast Review for Biosimilar by Geographic Region

12.1 Global Biosimilar Market Size Forecast by Region

12.1.1 Global Biosimilar Forecast by Region (2023-2028)

12.1.2 Global Biosimilar Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Biosimilar Forecast by Type

12.7 Global Biosimilar Forecast by Application

13 Key Players Analysis

13.1 Allergan plc

13.1.1 Allergan plc Company Information

13.1.2 Allergan plc Biosimilar Product Offered

13.1.3 Allergan plc Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan plc Main Business Overview

13.1.5 Allergan plc Latest Developments

13.2 BIOCAD

13.2.1 BIOCAD Company Information

13.2.2 BIOCAD Biosimilar Product Offered

13.2.3 BIOCAD Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BIOCAD Main Business Overview

13.2.5 BIOCAD Latest Developments

13.3 Biocon

13.3.1 Biocon Company Information

13.3.2 Biocon Biosimilar Product Offered

13.3.3 Biocon Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biocon Main Business Overview

13.3.5 Biocon Latest Developments

13.4 BioXpress Therapeutics

13.4.1 BioXpress Therapeutics Company Information

13.4.2 BioXpress Therapeutics Biosimilar Product Offered

13.4.3 BioXpress Therapeutics Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 BioXpress Therapeutics Main Business Overview

13.4.5 BioXpress Therapeutics Latest Developments

13.5 Boehringer Ingelheim

13.5.1 Boehringer Ingelheim Company Information

13.5.2 Boehringer Ingelheim Biosimilar Product Offered

13.5.3 Boehringer Ingelheim Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Boehringer Ingelheim Main Business Overview

13.5.5 Boehringer Ingelheim Latest Developments

13.6 Celltrion

13.6.1 Celltrion Company Information

13.6.2 Celltrion Biosimilar Product Offered

13.6.3 Celltrion Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Celltrion Main Business Overview

13.6.5 Celltrion Latest Developments

13.7 Coherus BioSciences

13.7.1 Coherus BioSciences Company Information

13.7.2 Coherus BioSciences Biosimilar Product Offered

13.7.3 Coherus BioSciences Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Coherus BioSciences Main Business Overview

13.7.5 Coherus BioSciences Latest Developments

13.8 Dr. Reddy’s Laboratories

13.8.1 Dr. Reddy’s Laboratories Company Information

13.8.2 Dr. Reddy’s Laboratories Biosimilar Product Offered

13.8.3 Dr. Reddy’s Laboratories Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Dr. Reddy’s Laboratories Main Business Overview

13.8.5 Dr. Reddy’s Laboratories Latest Developments

13.9 Genor BioPharma

13.9.1 Genor BioPharma Company Information

13.9.2 Genor BioPharma Biosimilar Product Offered

13.9.3 Genor BioPharma Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Genor BioPharma Main Business Overview

13.9.5 Genor BioPharma Latest Developments

13.10 Intas Pharmaceuticals Limited

13.10.1 Intas Pharmaceuticals Limited Company Information

13.10.2 Intas Pharmaceuticals Limited Biosimilar Product Offered

13.10.3 Intas Pharmaceuticals Limited Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Intas Pharmaceuticals Limited Main Business Overview

13.10.5 Intas Pharmaceuticals Limited Latest Developments

13.11 Novartis

13.11.1 Novartis Company Information

13.11.2 Novartis Biosimilar Product Offered

13.11.3 Novartis Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Novartis Main Business Overview

13.11.5 Novartis Latest Developments

13.12 Pfizer

13.12.1 Pfizer Company Information

13.12.2 Pfizer Biosimilar Product Offered

13.12.3 Pfizer Biosimilar Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Pfizer Main Business Overview

13.12.5 Pfizer Latest Developments

14 Research Findings and Conclusion

Table 1. Biosimilar Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Biosimilar Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Human Growth Hormones

Table 4. Major Players of Monoclonal Antibodies

Table 5. Major Players of Insulin

Table 6. Major Players of Peptides

Table 7. Major Players of Erythropoietin

Table 8. Major Players of Others

Table 9. Global Biosimilar Sales by Type (2017-2022) & (K Units)

Table 10. Global Biosimilar Sales Market Share by Type (2017-2022)

Table 11. Global Biosimilar Revenue by Type (2017-2022) & ($ million)

Table 12. Global Biosimilar Revenue Market Share by Type (2017-2022)

Table 13. Global Biosimilar Sale Price by Type (2017-2022) & (US$/Unit)

Table 14. Global Biosimilar Sales by Application (2017-2022) & (K Units)

Table 15. Global Biosimilar Sales Market Share by Application (2017-2022)

Table 16. Global Biosimilar Revenue by Application (2017-2022)

Table 17. Global Biosimilar Revenue Market Share by Application (2017-2022)

Table 18. Global Biosimilar Sale Price by Application (2017-2022) & (US$/Unit)

Table 19. Global Biosimilar Sales by Company (2020-2022) & (K Units)

Table 20. Global Biosimilar Sales Market Share by Company (2020-2022)

Table 21. Global Biosimilar Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Biosimilar Revenue Market Share by Company (2020-2022)

Table 23. Global Biosimilar Sale Price by Company (2020-2022) & (US$/Unit)

Table 24. Key Manufacturers Biosimilar Producing Area Distribution and Sales Area

Table 25. Players Biosimilar Products Offered

Table 26. Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Biosimilar Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Biosimilar Sales Market Share Geographic Region (2017-2022)

Table 31. Global Biosimilar Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Biosimilar Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Biosimilar Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Biosimilar Sales Market Share by Country/Region (2017-2022)

Table 35. Global Biosimilar Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Biosimilar Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Biosimilar Sales by Country (2017-2022) & (K Units)

Table 38. Americas Biosimilar Sales Market Share by Country (2017-2022)

Table 39. Americas Biosimilar Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Biosimilar Revenue Market Share by Country (2017-2022)

Table 41. Americas Biosimilar Sales by Type (2017-2022) & (K Units)

Table 42. Americas Biosimilar Sales Market Share by Type (2017-2022)

Table 43. Americas Biosimilar Sales by Application (2017-2022) & (K Units)

Table 44. Americas Biosimilar Sales Market Share by Application (2017-2022)

Table 45. APAC Biosimilar Sales by Region (2017-2022) & (K Units)

Table 46. APAC Biosimilar Sales Market Share by Region (2017-2022)

Table 47. APAC Biosimilar Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Biosimilar Revenue Market Share by Region (2017-2022)

Table 49. APAC Biosimilar Sales by Type (2017-2022) & (K Units)

Table 50. APAC Biosimilar Sales Market Share by Type (2017-2022)

Table 51. APAC Biosimilar Sales by Application (2017-2022) & (K Units)

Table 52. APAC Biosimilar Sales Market Share by Application (2017-2022)

Table 53. Europe Biosimilar Sales by Country (2017-2022) & (K Units)

Table 54. Europe Biosimilar Sales Market Share by Country (2017-2022)

Table 55. Europe Biosimilar Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Biosimilar Revenue Market Share by Country (2017-2022)

Table 57. Europe Biosimilar Sales by Type (2017-2022) & (K Units)

Table 58. Europe Biosimilar Sales Market Share by Type (2017-2022)

Table 59. Europe Biosimilar Sales by Application (2017-2022) & (K Units)

Table 60. Europe Biosimilar Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Biosimilar Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Biosimilar Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Biosimilar Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Biosimilar Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Biosimilar Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Biosimilar Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Biosimilar Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Biosimilar Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Biosimilar

Table 70. Key Market Challenges & Risks of Biosimilar

Table 71. Key Industry Trends of Biosimilar

Table 72. Biosimilar Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Biosimilar Distributors List

Table 75. Biosimilar Customer List

Table 76. Global Biosimilar Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Biosimilar Sales Market Forecast by Region

Table 78. Global Biosimilar Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Biosimilar Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Biosimilar Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Biosimilar Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Biosimilar Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Biosimilar Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Biosimilar Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Biosimilar Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Biosimilar Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Biosimilar Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Biosimilar Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Biosimilar Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Biosimilar Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Biosimilar Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Biosimilar Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Biosimilar Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Biosimilar Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Biosimilar Revenue Market Share Forecast by Application (2023-2028)

Table 96. Allergan plc Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 97. Allergan plc Biosimilar Product Offered

Table 98. Allergan plc Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 99. Allergan plc Main Business

Table 100. Allergan plc Latest Developments

Table 101. BIOCAD Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 102. BIOCAD Biosimilar Product Offered

Table 103. BIOCAD Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 104. BIOCAD Main Business

Table 105. BIOCAD Latest Developments

Table 106. Biocon Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 107. Biocon Biosimilar Product Offered

Table 108. Biocon Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 109. Biocon Main Business

Table 110. Biocon Latest Developments

Table 111. BioXpress Therapeutics Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 112. BioXpress Therapeutics Biosimilar Product Offered

Table 113. BioXpress Therapeutics Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 114. BioXpress Therapeutics Main Business

Table 115. BioXpress Therapeutics Latest Developments

Table 116. Boehringer Ingelheim Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 117. Boehringer Ingelheim Biosimilar Product Offered

Table 118. Boehringer Ingelheim Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 119. Boehringer Ingelheim Main Business

Table 120. Boehringer Ingelheim Latest Developments

Table 121. Celltrion Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 122. Celltrion Biosimilar Product Offered

Table 123. Celltrion Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 124. Celltrion Main Business

Table 125. Celltrion Latest Developments

Table 126. Coherus BioSciences Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 127. Coherus BioSciences Biosimilar Product Offered

Table 128. Coherus BioSciences Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 129. Coherus BioSciences Main Business

Table 130. Coherus BioSciences Latest Developments

Table 131. Dr. Reddy’s Laboratories Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 132. Dr. Reddy’s Laboratories Biosimilar Product Offered

Table 133. Dr. Reddy’s Laboratories Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 134. Dr. Reddy’s Laboratories Main Business

Table 135. Dr. Reddy’s Laboratories Latest Developments

Table 136. Genor BioPharma Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 137. Genor BioPharma Biosimilar Product Offered

Table 138. Genor BioPharma Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 139. Genor BioPharma Main Business

Table 140. Genor BioPharma Latest Developments

Table 141. Intas Pharmaceuticals Limited Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 142. Intas Pharmaceuticals Limited Biosimilar Product Offered

Table 143. Intas Pharmaceuticals Limited Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 144. Intas Pharmaceuticals Limited Main Business

Table 145. Intas Pharmaceuticals Limited Latest Developments

Table 146. Novartis Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 147. Novartis Biosimilar Product Offered

Table 148. Novartis Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 149. Novartis Main Business

Table 150. Novartis Latest Developments

Table 151. Pfizer Basic Information, Biosimilar Manufacturing Base, Sales Area and Its Competitors

Table 152. Pfizer Biosimilar Product Offered

Table 153. Pfizer Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 154. Pfizer Main Business

Table 155. Pfizer Latest Developments

List of Figures

Figure 1. Picture of Biosimilar

Figure 2. Biosimilar Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Biosimilar Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Biosimilar Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Biosimilar Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Human Growth Hormones

Figure 10. Product Picture of Monoclonal Antibodies

Figure 11. Product Picture of Insulin

Figure 12. Product Picture of Peptides

Figure 13. Product Picture of Erythropoietin

Figure 14. Product Picture of Others

Figure 15. Global Biosimilar Sales Market Share by Type in 2021

Figure 16. Global Biosimilar Revenue Market Share by Type (2017-2022)

Figure 17. Biosimilar Consumed in Oncology

Figure 18. Global Biosimilar Market: Oncology (2017-2022) & (K Units)

Figure 19. Biosimilar Consumed in Chronic and Autoimmune Diseases

Figure 20. Global Biosimilar Market: Chronic and Autoimmune Diseases (2017-2022) & (K Units)

Figure 21. Biosimilar Consumed in Growth Hormone Deficiency

Figure 22. Global Biosimilar Market: Growth Hormone Deficiency (2017-2022) & (K Units)

Figure 23. Biosimilar Consumed in Infectious Diseases

Figure 24. Global Biosimilar Market: Infectious Diseases (2017-2022) & (K Units)

Figure 25. Biosimilar Consumed in Others

Figure 26. Global Biosimilar Market: Others (2017-2022) & (K Units)

Figure 27. Global Biosimilar Sales Market Share by Application (2017-2022)

Figure 28. Global Biosimilar Revenue Market Share by Application in 2021

Figure 29. Biosimilar Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Biosimilar Revenue Market Share by Company in 2021

Figure 31. Global Biosimilar Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Biosimilar Revenue Market Share by Geographic Region in 2021

Figure 33. Global Biosimilar Sales Market Share by Region (2017-2022)

Figure 34. Global Biosimilar Revenue Market Share by Country/Region in 2021

Figure 35. Americas Biosimilar Sales 2017-2022 (K Units)

Figure 36. Americas Biosimilar Revenue 2017-2022 ($ Millions)

Figure 37. APAC Biosimilar Sales 2017-2022 (K Units)

Figure 38. APAC Biosimilar Revenue 2017-2022 ($ Millions)

Figure 39. Europe Biosimilar Sales 2017-2022 (K Units)

Figure 40. Europe Biosimilar Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Biosimilar Sales 2017-2022 (K Units)

Figure 42. Middle East & Africa Biosimilar Revenue 2017-2022 ($ Millions)

Figure 43. Americas Biosimilar Sales Market Share by Country in 2021

Figure 44. Americas Biosimilar Revenue Market Share by Country in 2021

Figure 45. United States Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Biosimilar Sales Market Share by Region in 2021

Figure 50. APAC Biosimilar Revenue Market Share by Regions in 2021

Figure 51. China Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Biosimilar Sales Market Share by Country in 2021

Figure 58. Europe Biosimilar Revenue Market Share by Country in 2021

Figure 59. Germany Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Biosimilar Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Biosimilar Revenue Market Share by Country in 2021

Figure 66. Egypt Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Biosimilar Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Biosimilar in 2021

Figure 72. Manufacturing Process Analysis of Biosimilar

Figure 73. Industry Chain Structure of Biosimilar

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles